06:58 AM EDT, 08/04/2026 (MT Newswires) -- IDEXX Laboratories ( IDXX ) reported Q2 comparable earnings Tuesday of $4.07 per share, up from $3.53 a year earlier.

Analysts polled by FactSet expected $3.94.

Revenue for the quarter ended June 30 was $1.22 billion, compared with $1.11 billion a year earlier.

Analysts expected $1.20 billion.

The company raised its 2026 EPS guidance to between $14.69 and $14.94, from $14.45 to $14.90 previously. Revenue outlook for the year was narrowed to between $4.70 billion and $4.75 billion, from the previous range of $4.68 billion to $4.76 billion. Analysts expect $14.65 in EPS on revenue of $4.71 billion.

Shares of IDEXX Laboratories ( IDXX ) were up 1.1% premarket Tuesday.